216 related articles for article (PubMed ID: 16325708)
41. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
[TBL] [Abstract][Full Text] [Related]
42. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.
Liu WN; Fu KL; Gao HY; Shang YY; Wang ZH; Jiang GH; Zhang Y; Zhang W; Zhong M
PLoS One; 2012; 7(7):e37659. PubMed ID: 22815685
[TBL] [Abstract][Full Text] [Related]
43. Beta1-adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome.
Paavonen KJ; Swan H; Piippo K; Laitinen P; Fodstad H; Sarna S; Toivonen L; Kontula K; Viitasalo M
Int J Cardiol; 2007 May; 118(2):197-202. PubMed ID: 17023080
[TBL] [Abstract][Full Text] [Related]
44. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
Greenfield DS; Liebmann JM; Ritch R; Krupin T;
Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318
[TBL] [Abstract][Full Text] [Related]
45. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
46. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
[TBL] [Abstract][Full Text] [Related]
47. beta1-Adrenoceptor gene polymorphism predicts long-term changes in body weight.
Linné Y; Dahlman I; Hoffstedt J
Int J Obes (Lond); 2005 May; 29(5):458-62. PubMed ID: 15685248
[TBL] [Abstract][Full Text] [Related]
48. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
[TBL] [Abstract][Full Text] [Related]
49. Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor.
Scharin Täng M; Lindberg E; Grüner Sveälv B; Magnusson Y; Andersson B
J Heart Lung Transplant; 2007 Sep; 26(9):915-20. PubMed ID: 17845930
[TBL] [Abstract][Full Text] [Related]
50. Randomized comparison of 1-Site and 2-Site phacotrabeculectomy with 3-year follow-up.
Cotran PR; Roh S; McGwin G
Ophthalmology; 2008 Mar; 115(3):447-454.e1. PubMed ID: 17825417
[TBL] [Abstract][Full Text] [Related]
51. Beta1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy.
Fragoso JM; Rodríguez-Pérez JM; González J; Cruz D; Pérez-Méndez O; de Jesus García J; de la Peña A; Arce M; Reyes PA; Vargas-Alarcón G
Exp Mol Pathol; 2006 Jun; 80(3):279-82. PubMed ID: 16487965
[TBL] [Abstract][Full Text] [Related]
52. Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes.
Wang RF; Podos SM; Mittag TW; Yokoyoma T
Exp Eye Res; 2005 May; 80(5):629-32. PubMed ID: 15862169
[TBL] [Abstract][Full Text] [Related]
53. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure.
Lam DS; Leung DY; Tham CC; Li FC; Kwong YY; Chiu TY; Fan DS
Ophthalmology; 2008 Jul; 115(7):1134-40. PubMed ID: 18164064
[TBL] [Abstract][Full Text] [Related]
54. Intraocular pressure response to topical beta-blockers associated with an ADRB2 single-nucleotide polymorphism.
McCarty CA; Burmester JK; Mukesh BN; Patchett RB; Wilke RA
Arch Ophthalmol; 2008 Jul; 126(7):959-63. PubMed ID: 18625943
[TBL] [Abstract][Full Text] [Related]
55. Sustained perimacular vascular and visual response to topical beta blockers in normal human eyes.
Sponsel WE
Brain Res Bull; 2004 Feb; 62(6):529-35. PubMed ID: 15036568
[TBL] [Abstract][Full Text] [Related]
56. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
57. The effect of intravitreal triamcinolone on intraocular pressure.
Kramar M; Vu L; Whitson JT; He YG
Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
[TBL] [Abstract][Full Text] [Related]
58. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
[TBL] [Abstract][Full Text] [Related]
59. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
Wang RF; Gagliuso DJ; Podos SM
J Glaucoma; 2008; 17(1):73-8. PubMed ID: 18303390
[TBL] [Abstract][Full Text] [Related]
60. The Arg389Gly beta1-adrenergic receptor gene polymorphism and susceptibility to faint during head-up tilt test.
Márquez MF; Hernández-Pacheco G; Hermosillo AG; Gómez JR; Cárdenas M; Vargas-Alarcón G
Europace; 2007 Aug; 9(8):585-8. PubMed ID: 17463065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
